经直肠拭子与直肠拭子对比检测产毒艰难梭菌无症状携带者。
Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.
机构信息
Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.
出版信息
J Clin Microbiol. 2013 Oct;51(10):3421-2. doi: 10.1128/JCM.01418-13. Epub 2013 Aug 7.
Abstract
For long-term care and spinal cord injury patients, the sensitivity, specificity, and positive and negative predictive values of perirectal versus rectal cultures for detection of asymptomatic carriers of Clostridium difficile were 95%, 100%, 100%, and 97%, respectively. Perirectal cultures provide an accurate method to detect asymptomatic carriers of C. difficile.
摘要
对于长期护理和脊髓损伤患者，经直肠与直肠拭子培养检测难辨梭状芽孢杆菌无症状携带者的敏感性、特异性、阳性预测值和阴性预测值分别为 95%、100%、100%和 97%。经直肠培养提供了一种准确的方法来检测难辨梭状芽孢杆菌的无症状携带者。
相似文献
1
Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.经直肠拭子与直肠拭子对比检测产毒艰难梭菌无症状携带者。
J Clin Microbiol. 2013 Oct;51(10):3421-2. doi: 10.1128/JCM.01418-13. Epub 2013 Aug 7.
2
Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB.经选择性肉汤预扩增和实时 PCR 检测 tcdB 对直肠拭子进行艰难梭菌的监测。
J Clin Microbiol. 2011 Nov;49(11):3788-93. doi: 10.1128/JCM.00679-11. Epub 2011 Aug 31.
3
Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.商业 PCR 检测法和临床预测规则在检测无症状携带产毒艰难梭菌中的应用。
J Clin Microbiol. 2014 Jan;52(1):315-8. doi: 10.1128/JCM.01852-13. Epub 2013 Oct 23.
4
Comparison of rectal swabs and fecal samples for the detection of infections with a new in-house PCR assay.比较直肠拭子和粪便样本在新型内部 PCR 检测中的应用。
Microbiol Spectr. 2024 Jun 4;12(6):e0022524. doi: 10.1128/spectrum.00225-24. Epub 2024 Apr 30.
5
Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.评估一种新的分子检测方法，BD Max Cdiff，用于检测粪便样本中的产毒艰难梭菌。
J Clin Microbiol. 2012 Sep;50(9):3089-90. doi: 10.1128/JCM.01250-12. Epub 2012 Jul 3.
6
Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.评估环介导等温扩增检测技术用于诊断艰难梭菌感染。
J Clin Microbiol. 2011 Jul;49(7):2714-6. doi: 10.1128/JCM.01835-10. Epub 2011 Apr 27.
7
Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.无症状携带者中产毒艰难梭菌的环境脱落：一项前瞻性观察研究。
Clin Microbiol Infect. 2020 Aug;26(8):1052-1057. doi: 10.1016/j.cmi.2019.12.011. Epub 2020 Jan 3.
8
Detection of toxigenic colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation.检测因化疗或造血细胞移植而住院的患者的产毒定植情况。
J Med Microbiol. 2018 Jul;67(7):976-981. doi: 10.1099/jmm.0.000774.
9
Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.医院收治的无症状患者粪便中艰难梭菌的检测
J Clin Microbiol. 2017 Feb;55(2):403-411. doi: 10.1128/JCM.01858-16. Epub 2016 Nov 16.
10
A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.一种具有成本效益的产毒艰难梭菌检测方法：使用 ChromID 艰难梭菌琼脂进行产毒培养。
J Clin Microbiol. 2014 Feb;52(2):671-3. doi: 10.1128/JCM.03113-13. Epub 2013 Dec 11.
引用本文的文献
1
Comparison of rectal swabs and fecal samples for the detection of infections with a new in-house PCR assay.比较直肠拭子和粪便样本在新型内部 PCR 检测中的应用。
Microbiol Spectr. 2024 Jun 4;12(6):e0022524. doi: 10.1128/spectrum.00225-24. Epub 2024 Apr 30.
2
Diagnostic Guidance for C. difficile Infections.艰难梭菌感染的诊断指南。
Adv Exp Med Biol. 2024;1435:33-56. doi: 10.1007/978-3-031-42108-2_3.
3
Comparison of nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs.比较使用新鲜和冷冻粪便标本和直肠拭子的核酸扩增试验（NAAT）结果。
J Clin Microbiol. 2024 Jan 17;62(1):e0103723. doi: 10.1128/jcm.01037-23. Epub 2023 Dec 11.
4
Acquisition and carriage of genetically diverse multi-drug resistant gram-negative bacilli in hospitalised newborns in The Gambia.冈比亚住院新生儿中基因多样的多重耐药革兰氏阴性杆菌的获得与携带情况。
Commun Med (Lond). 2023 Jun 3;3(1):79. doi: 10.1038/s43856-023-00309-6.
5
Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.从重症监护病房无症状携带患者中确定艰难梭菌感染的相对风险的基因组决定因素。
Clin Infect Dis. 2021 Oct 5;73(7):e1727-e1736. doi: 10.1093/cid/ciaa894.
6
Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection.评估直肠拭子在艰难梭菌感染实验室诊断中的应用。
J Clin Microbiol. 2018 Jun 25;56(7). doi: 10.1128/JCM.00426-18. Print 2018 Jul.
7
Understanding Clostridium difficile Colonization.了解艰难梭菌定植。
Clin Microbiol Rev. 2018 Mar 14;31(2). doi: 10.1128/CMR.00021-17. Print 2018 Apr.
8
Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.使用 cobas Cdiff 检测试验对艰难梭菌定植进行主动监测检测的验证。
J Clin Microbiol. 2018 Mar 26;56(4). doi: 10.1128/JCM.01553-17. Print 2018 Apr.
9
Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.医院收治的无症状患者粪便中艰难梭菌的检测
J Clin Microbiol. 2017 Feb;55(2):403-411. doi: 10.1128/JCM.01858-16. Epub 2016 Nov 16.
本文引用的文献
1
Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.应用多位点可变串联重复分析基因分型技术来确定无症状携带者在艰难梭菌传播中的作用。
Clin Infect Dis. 2013 Oct;57(8):1094-102. doi: 10.1093/cid/cit475. Epub 2013 Jul 23.
2
Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.经直肠拭子标本在艰难梭菌感染诊断中的应用。
Clin Infect Dis. 2012 Dec;55(11):1527-30. doi: 10.1093/cid/cis707. Epub 2012 Aug 21.
3
Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.评价口服 VP20621 混悬液，即无毒素艰难梭菌 M3 株孢子，在健康受试者中的效果。
Antimicrob Agents Chemother. 2012 Oct;56(10):5224-9. doi: 10.1128/AAC.00913-12. Epub 2012 Jul 30.
4
Host and pathogen factors for Clostridium difficile infection and colonization.艰难梭菌感染和定植的宿主和病原体因素。
N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.
5
Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.脊髓损伤病房患者艰难梭菌和耐万古霉素肠球菌定植的流行病学
J Spinal Cord Med. 2011;34(1):22-7. doi: 10.1179/107902610x12883422813822.
6
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.抗菌药物在肿瘤中性粒细胞减少患者应用的临床实践指南：美国传染病学会 2010 年更新版。
Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.
7
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).艰难梭菌感染临床实践指南：美国医疗保健流行病学学会（SHEA）和美国传染病学会（IDSA）2010 年更新版。
Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.
8
Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.用于艰难梭菌分离的高效低成本改良选择性培养基
J Clin Microbiol. 2009 Feb;47(2):397-400. doi: 10.1128/JCM.01591-08. Epub 2008 Dec 10.
9
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.无症状携带者是长期护理机构居民中流行和非流行艰难梭菌菌株传播的潜在来源。
Clin Infect Dis. 2007 Oct 15;45(8):992-8. doi: 10.1086/521854. Epub 2007 Sep 4.
10
Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.与粪便样本相比，直肠周围拭子和直肠拭子检测胃肠道中耐氟喹诺酮大肠杆菌的检测特征。
Antimicrob Agents Chemother. 2005 Feb;49(2):798-800. doi: 10.1128/AAC.49.2.798-800.2005.
Zotero 插件